Patents (1436 Stem Cell Patents)

Class: Use (276)

Order by:
<< | < | 5 6 7 8 9 10 11 12 13 | > | >>


Use of human embryonic stem cells for drug screening and toxicity testing

Patent Number: 7041438

This is a very broad patent that essentially covers all drug screening using a specific type of stem cells. The inventors describe these stem cells as "primate Pluripotent Stem cells" (pPS cells), thus including pre-embryonic, embryonic, or fetal tissue-derived cells that can be induced to differentiated into progeny of the three germinal layers: endoderm, mesoderm, and ectoderm. This...

Inventors: Carpenter, Melissa K. (London, CA); Inokuma, Margaret S. (San Jose, CA); Xu, Chunhui (Palo Alto, CA)
Assignee: Geron Corporation (Menlo Park, CA)
Date of First Priority Issue: Thursday June 22nd, 2000

Autogenous cell patch cardio myoplasty and advanced muscle graft implantation system

Patent Number: 6435190

This patent teaches what appears to be a surgical method for producing an autograft that can cover lesions in the heart. This is important since after a heart attack, there is scar tissue formation, and the heart starts to lose function. The patent also covers ways in which autologous stem cells may be administered.

Inventors: Taheri, Syde A. (Buffalo, NY); Leonhardt, Howard J. (Weston, FL)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Wednesday June 14th, 2000

Method for enhancing engraftment of cells using mesenchymal progenitor cells

Patent Number: 7,442,390

Stem cell transplantation in the form of cord blood, mobilized peripheral blood, or bone marrow, has saved many lives.  One of the limiting factors of this procedure is graft versus host disease (GVHD).  The other is poor engraftment.  This is particularly important in situations...

Inventors: Seshi; Beerelli (Torrance, CA)
Assignee: University of South Florida (Tampa, FL)
Date of First Priority Issue: Monday June 5th, 2000

Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state

Patent Number: 7049072

It is known from the literature that the non-tumor stroma surrounding the tumor plays an important role in the growth of the tumor by facilitating angiogenesis, providing growth factors, etc. In hematological malignancies, the fact that donor-derived leukemic relapse occurs in some individuals suggests that stromal elements may be responsible, or associated with leukemic transformation...

Inventor: Seshi, Beerelli (Torrance, CA)
Assignee: University of South Florida (Tampa, unknown)
Date of First Priority Issue: Monday June 5th, 2000

Surface modifications for enhanced epithelialization

Patent Number: 6689165

This patent teaches how to accelerate healing of epithelial cells of the cornea through administration of an optical polymer that consists, in part of a hydrogel. The devices and compositions thought are useful for stimulation of stem cells associated with production of corneal epithelial cells.

Inventors: Jacob, Jean T. (New Orleans, LA); Bi, Jingjing (River Ridge, LA)
Assignee: Board of Supervisors of Louisana State University and Agricultural and Mechanical College (Baton Rouge, LA)
Date of First Priority Issue: Wednesday May 31st, 2000

Neuroprotective peptides

Patent Number: 7,259,146

This patent covers specific peptides derived from erythropoietin, as well as from other molecules, that have ability to increase neurite outgrowth in cell culture. Specifically, the claims appear to be restricted only to a method of increasing neurite outgrowth in cell culture. The neuroprotective roles of erythropoietin have been known for many years and have been assessed and are being...

Inventors: Smith-Swintosky; Virginia (Hatfield, PA), Renzi; Michael (Harleysville, PA), Plata-Salaman; Carlos (Ambler, PA), Jolliffe; Linda (Belle Mead, PA), Farrell; Francis (Doylestown, PA), Johnson; Dana (Upper Black Eddy, PA)
Assignee: Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ)
Date of First Priority Issue: Friday May 26th, 2000

Microinjection of cryoprotectants for preservation of cells

Patent Number: 7094601

This patent is useful for cryopreservation of extremely sensitive cells such as oocytes and stem cells. Particularly, the patent deals with microinjection of various agents that protect cells during cryopreservation. The patent has 2 independent claims. The first covers the culture of oocytes (the concept that "culture" will be frozen) such that a cryopreservation agent is injected...

Inventors: Toner, Mehmet (Wellesley, MA); Eroglu, Ali (Augusta, GA); Toth, Thomas (Sudbury, MA)
Assignee: The General Hospital Corporation (Boston, MA)
Date of First Priority Issue: Tuesday May 16th, 2000

Conditioned cell culture medium compositions and methods of use

Patent Number: 7,118,746

This patent covers protection of keratinocytes from a variety of stresses by administration of conditioned media from a variety of stem cell sources. This patent is useful for cosmetics and also for skin regeneration.

Inventors: Naughton; Gail K. (Del Mar, CA), Horwitz; David L. (San Diego, CA), Applegate; Mark A. (San Diego, CA), Zeltinger; Joan (San Diego, CA), Mansbridge; Jonathan N. (La Jolla, CA), Kern; Andreas (San Diego, CA), Landeen; Lee K. (San Diego, CA), Ratcliffe; Ant
Assignee: SkinMedica, Inc. (Carlsbad, CA)
Date of First Priority Issue: Friday May 12th, 2000

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

Patent Number: 7,431,932

Activation of innate immune responses is associated in some situations with anti-tumor effects.  It is known that viruses activate various cells of the innate immune system such as interferon producing plasmacytoid dendritic cells and natural killer cells.  In tumor immunology, it would be...

Inventors: Morris; Donald (Calgary, CA), Thompson; Bradley G. (Calgary, CA), Coffey; Matthew C. (Calgary, CA)
Assignee: Oncolytics Biotech Inc. (Calgary, Alberta, unknown)
Date of First Priority Issue: Wednesday May 3rd, 2000

Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs

Patent Number: 6808702

This patent is very interesting in that it provides a source of nitric oxide through the use of fetal and embryonically derived neural stem cells. The neural stem cells can be administered by various means in order to correct gastrointestinal deficiencies.

Inventors: Pasricha, Pankaj J. (Houston, TX); Micci, Maria A. (Dickinson, TX)
Assignee: Board of Regents, the University of Texas System (Austin, TX)
Date of First Priority Issue: Thursday April 13th, 2000

Order by:
<< | < | 5 6 7 8 9 10 11 12 13 | > | >>

Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent